BackgroundCyclin E2 is a member of the cyclin E family that can associate with and activate Cdk2. It is essential for the control of the cell cycle at the late G1 and early S phase. Cyclin E2 associates with Cdk2 in a functional kinase complex that is inhibited by both p27 (Kip1) and p21 (Cip1). Cyclin E2 is high expressed in adult testis, thymus and brain. Abnormally high levels of cyclin E expression have frequently been observed in human cancers.
Product Information
Clone Number No:40-89
Positive controlHela
Project IDPK011
Molecular Weight48kDa
Cellular localizationNucleus
Form Or Antibody
Form of AntibodyMouse monoclonal IgG1 in 1*TBS (pH7.4), 0.5%BSA, 25%Glycerol. Preservative: 0.05% Sodium Azide.
Storage/StabilityStore at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Specificty Sensitivity
Specificity/SensitivityThis antibody is produced by immunizing mouse with a synthetic peptide (KLH-coupled) corresponding to near C-terminal residues of Cyclin E2.
ReferencesLauper N., Beck A.R.P., Cariou S., Richman L., Hofmann K., Reith W., Slingerland J.M., Amati B.; "Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle."; Oncogene 17:2637-2643(1998).
Zariwala M., Liu J., Xiong Y.; "Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins."; Oncogene 17:2787-2798(1998).